Since its establishment in November 2017, Arontier is an artificial intelligence-driven drug discovery start-up company using bioinformatics, pharmacogenomics for incurable and rare diseases.
Drug development is becoming unprofitable more than before. This can mainly be attributed to large average development costs, low clinical trial drugs success rate, and low ROI because of reduced healthcare expenditure and focused on rare diseases. However, AI can be applied in drug discovery to make the process faster significantly and statistically. As a result, innovative technologies have been creating an environment where medical advances can be quickly realized.
Based on our own unique technology and extensive data, we are constantly challenging ourselves with a mission to conquer incurable diseases and deliver healthy life and happiness to countless suffering patients.